These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 21277882)

  • 21. Advances in corticosteroid therapy for ocular inflammation: loteprednol etabonate.
    Comstock TL; Decory HH
    Int J Inflam; 2012; 2012():789623. PubMed ID: 22536546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of some new steroidal [16alpha,17alpha-d]-isoxazolines.
    Chowdhury P; Das AM; Goswami P
    Steroids; 2005 Jul; 70(8):494-8. PubMed ID: 15894032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemistry of loteprednol etabonate and related steroids. II. Reactions at ring C and NMR structural studies of the resulting compounds.
    Rachwal S; Druzgala P; Liu ZZ; Vlasak J; Brewster ME; Pop E
    Steroids; 1998 Apr; 63(4):193-201. PubMed ID: 9589553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Substituted 16alpha,17alpha-cyclohexanopregnanes: the anionic oxy-Cope rearrangement of 3beta-tert-butyldimethylsilyloxy-19-hydroxy-19-vinyl-16alpha,17alpha-cyclohexapregn-5-en-20-one].
    Levina IS; Kulikova LE; Shashkov AS; Galakhova TN; Kamernitskiĭ AV
    Bioorg Khim; 2007; 33(3):332-6. PubMed ID: 17682389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potent analogues of etiprednol dicloacetate, a second generation of soft corticosteroids.
    Bodor N; Zubovics Z; Kurucz I; Sólyom S; Bodor E
    J Pharm Pharmacol; 2017 Dec; 69(12):1745-1753. PubMed ID: 28980320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new and convenient synthesis of the 17alpha,21-diacetoxy-20-oxopregnane side-chain.
    Boar RB; McGhie JF; Robinson M; Barton DH
    J Chem Soc Perkin 1; 1975; (13):1242-4. PubMed ID: 1171882
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of cyclodextrins on the solubility and stability of a novel soft corticosteroid, loteprednol etabonate.
    Bodor N; Drustrup J; Wu W
    Pharmazie; 2000 Mar; 55(3):206-9. PubMed ID: 10756542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of simultaneous quantification method of loteprednol etabonate (LE) and its acidic metabolites, and analysis of LE metabolism in rat.
    Samir A; Kage A; Ohura K; Imai T
    Xenobiotica; 2019 May; 49(5):569-576. PubMed ID: 29781759
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of seasonal allergic conjunctivitis with ophthalmic corticosteroids: in search of the perfect ocular corticosteroids in the treatment of allergic conjunctivitis.
    Bielory BP; Perez VL; Bielory L
    Curr Opin Allergy Clin Immunol; 2010 Oct; 10(5):469-77. PubMed ID: 20720489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose Uniformity of Topical Corticosteroids: A Simulated Trial of Fluorometholone Acetate 0.1% and Loteprednol Etabonate Gel 0.5.
    Stevens CE; Bennion JL; Caldwell MC; Townley JR; Apsey DA; Schwertner HA
    J Ocul Pharmacol Ther; 2017 Mar; 33(2):111-114. PubMed ID: 28140772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comments concerning "Pharmacokinetic characterization and tissue distribution of the new glucocorticoid soft drug loteprednol etabonate in rats and dogs".
    Sloan KB; Perrin JH
    J Pharm Sci; 1994 Jul; 83(7):1066-8. PubMed ID: 7965668
    [No Abstract]   [Full Text] [Related]  

  • 32. Loteprednol etabonate. Alrex, Lotemax, Loteprednol, Loterox.
    Drugs R D; 2002; 3(3):154-7. PubMed ID: 12099159
    [No Abstract]   [Full Text] [Related]  

  • 33. Loteprednol etabonate: a soft steroid for the treatment of allergic diseases of the airways.
    Szelenyi I; Hochhaus G; Heer S; Kusters S; Marx D; Poppe H; Engel J
    Drugs Today (Barc); 2000 May; 36(5):313-20. PubMed ID: 12861354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expeditious and convenient synthesis of pregnanes and its glycosides as potential anti-dyslipidemic and anti-oxidant agents.
    Sethi A; Maurya A; Tewari V; Srivastava S; Faridi S; Bhatia G; Khan MM; Khanna AK; Saxena JK
    Bioorg Med Chem; 2007 Jul; 15(13):4520-7. PubMed ID: 17485213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulfated pregnane glycosides from Periploca graeca.
    Siciliano T; Bader A; De Tommasi N; Morelli I; Braca A
    J Nat Prod; 2005 Aug; 68(8):1164-8. PubMed ID: 16124754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New pregnane steroids from Turraea pubescens.
    Wang XN; Fan CQ; Yue JM
    Steroids; 2006 Aug; 71(8):720-4. PubMed ID: 16765400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and delta1-cortienic acid excretion after intravenous administration of prednisolone and loteprednol etabonate in rats.
    Wu WM; Tang Y; Buchwald P; Bodor N
    Pharmazie; 2010 Jun; 65(6):412-6. PubMed ID: 20614688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility of localized immunosuppression: 2. PLA microspheres for the sustained local delivery of a soft immunosuppressant.
    Pinto E; Zhang B; Song S; Bodor N; Buchwald P; Hochhaus G
    Pharmazie; 2010 Jun; 65(6):429-35. PubMed ID: 20614691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design of novel soft corticosteroids.
    Bodor N
    Curr Probl Dermatol; 1993; 21():11-9. PubMed ID: 8299363
    [No Abstract]   [Full Text] [Related]  

  • 40. KPI-121 1% for pain and inflammation in ocular surgery.
    Beckman KA; Katz JA; Majmudar PA; Rips AG; Vaidya NS; Rostov AT
    Pain Manag; 2022 Jan; 12(1):17-23. PubMed ID: 34164994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.